Temple University-Main Line — Philadelphia, Pennsylvania

Temple University-Main Line is a clinical research site located in Philadelphia, Pennsylvania, United States 19140.

Crixeo Clinical Trials Trust Score: 91/100 (GOOD). This profile has not yet been claimed by the site owner.

Temple University-Main Line has participated in 1 clinical trials.

Therapeutic areas: Status Epilepticus.

Sponsors: Robert Silbergleit.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Philadelphia

Browse all research sites in Pennsylvania · View every site in Philadelphia

Sponsor Feasibility Report

Trust Score: 91/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Temple University-Main Line?

Temple University-Main Line has a Crixeo Trust Score of 91/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Temple University-Main Line conducted?

Temple University-Main Line has 1 clinical trials on record. Their work covers Status Epilepticus.

Is Temple University-Main Line accredited by Crixeo Clinical Trials?

Temple University-Main Line has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Temple University-Main Line?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.